Showing results (21-30 of 3,227) with videos related to
Sort By:
Pageof 323
Current Drug Metabolism|March 11, 2010
St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effectsSilvio Caccia, Marco GobbiCNS & Neurological Disorders Drug Targets|August 16, 2011
Chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS): a critical reviewChiara Zecca, Claudio GobbiEuropean Journal of Clinical Pharmacology|January 1, 1993
Deflazacort in the treatment of haematologic disordersM Gobbi, M ScudelettiJournal of Psychiatry & Neuroscience : JPN|August 27, 2013
Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacologyStefano Comai, Gabriella GobbiResearch in Developmental Disabilities|April 17, 2012
Effects of an exercise programme on anxiety in adults with intellectual disabilitiesAttilio Carraro, Erica GobbiThe Journal of Knee Surgery|February 17, 2009
Biological approaches for cartilage repairAlberto Gobbi, Lyndon BathanEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2000
Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: an in vivo microiontophoretic studyG Gobbi, L JaniriItalian Journal of Pediatrics|January 8, 2020
A reflection on the role of genetics in the concept of "epileptic encephalopathy", as emerged from the most recent ILEA classification of epilepsyAngelo Russo, Giuseppe GobbiPerceptual and Motor Skills|August 26, 2014
Exercise intervention to reduce depressive symptoms in adults with intellectual disabilitiesAttilio Carraro, Erica GobbiPageof 323